Acuren Corporation Insider Trading Activity

Accepted by SEC EDGAR 08/01/2025 - 06:05 PM EDT Learn about SEC filing dates

Insider Trade Summary

36,667 shares exercised/converted

Exercise 2 txns

Insider PIZZEY TALMAN

Role CHIEF EXECUTIVE OFFICER

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	36,667	$0.00	$0.00
Exercise	Common Stock	36,667	$0.00	$0.00
Holding	Performance Based Restricted Stock Units	--	--	--
Holding	Restricted Stock Units	--	--	--
Holding	Performance Based Restricted Stock Units	--	--	--

Holdings After Transaction: Restricted Stock Units — 146,666 contracts for 73,333 underlying shares (Direct); Common Stock — 436,667 shares (Direct); Performance Based Restricted Stock Units — 256,667 contracts (Direct)

Holdings Before and After: Restricted Stock Units, 183,333 to 146,666 contracts (Direct); Common Stock, 400,000 to 436,667 shares (Direct)

Footnotes (7)

1. F1. On July 30, 2025, 36,667 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
2. F2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
3. F3. These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
4. F4. Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
5. F5. Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.
6. F6. These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
7. F7. These performance restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PIZZEY TALMAN

(Last) (First) (Middle)

C/O ACUREN CORPORATION

14434 MEDICAL COMPLEX DRIVE, SUITE 100

(Street)

TOMBALL TX 77377

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACUREN CORP [ TIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/30/2025		M		36,667	A	$0(1)	436,667	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	07/30/2025		M		36,667		(3)	(3)	Common Stock	36,667	$0	73,333	D
Performance Based Restricted Stock Units	(4)							(5)	(5)	Common Stock	110,000		110,000	D
Restricted Stock Units	(2)							(6)	(6)	Common Stock	73,333		73,333	D
Performance Based Restricted Stock Units	(4)							(7)	(7)	Common Stock	146,667		146,667	D

Explanation of Responses:

1. On July 30, 2025, 36,667 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.

2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

3. These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).

4. Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

5. Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.

6. These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).

7. These performance restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.

	/s/ Fiona Sutherland, Attorney-in-Fact	08/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.